Alkem Laboratories

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss...

28 Oct, 2025 | 04:11pm • Source: BSE

Pursuant to Regulation 30 read with SEBI LODR Regulations, this is to inform you that the Company has received an appeal order passed by statutory...

01 Oct, 2025 | 03:11pm • Source: BSE

This is to inform you that today i.e. 26th September, 2025, the Company has entered into a Business Transfer Agreement with Alkem Wellness Limited, a...

26 Sep, 2025 | 05:28pm • Source: BSE

This is to inform you that the trading window will remain closed from 29th September, 2025 until the expiry of 48 hours after the date...

25 Sep, 2025 | 03:50pm • Source: BSE

This is to inform you that Mr. Amit Ghare, a Senior Management Personnel has tendered his resignation from the services of the Company on account...

25 Sep, 2025 | 03:29pm • Source: BSE

Pursuant to Regulation 30 of SEBI LODR Regulations, this is to inform you that the Company has received an order passed by the statutory authority...

24 Sep, 2025 | 02:30pm • Source: BSE

Pursuant to Regulation 30 of SEBI LODR Regulation, 2015, this is to inform you that the Company has received an order passed by the statutory...

22 Sep, 2025 | 08:30pm • Source: BSE

This is to intimate you that Alkem Laboratories Limited (the 'Company') launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer. A...

22 Sep, 2025 | 04:04pm • Source: BSE

Please find enclosed herewith the details of investor meetings scheduled to be held on 25th September, 2025, 26th September, 2025 and 30th September, 2025.

18 Sep, 2025 | 12:39pm • Source: BSE

Please find enclosed herewith the details of investor meeting scheduled to be held on 22nd September, 2025.

17 Sep, 2025 | 03:49pm • Source: BSE

Please find enclosed herewith the details of investor meetings scheduled to be held on 22nd September, 2025 and 25th September, 2025.

16 Sep, 2025 | 06:58pm • Source: BSE

In continuation to our intimation dated 03rd September, 2025, this is to inform that, the Analyst / Investor meeting as scheduled to be held on...

09 Sep, 2025 | 12:28pm • Source: BSE

Alkem Laboratories Limited has informed the Exchange about Schedule of meet

08 Sep, 2025 | 12:38pm • Source: NSE

Please find enclosed herewith the details of investor meetings scheduled to be held on 12th September, 2025, 17th September, 2025, 18th September, 2025, 19th September,...

08 Sep, 2025 | 12:28pm • Source: BSE

Please find enclosed herewith the details of investor meeting scheduled to be held on 09th September, 2025.

03 Sep, 2025 | 10:41am • Source: BSE

Details regarding the brief proceedings of the 51st AGM and the voting results of the business transacted thereat along with the Report of the Scrutinizer...

25 Aug, 2025 | 04:41pm • Source: BSE

Details regarding the brief proceedings of the 51st AGM of the Company and voting results of the business transacted thereat alongwith the report of the...

25 Aug, 2025 | 04:31pm • Source: BSE

This is to inform you that the Company has announced the launch of Olesoft Trucera moisturizing lotion, an advanced science-led formulation designed to restore hydration,...

19 Aug, 2025 | 12:53pm • Source: BSE

Alkem Laboratories Limited has informed the Exchange about Transcript of "Q1 FY2026 Earnings conference call" hosted by the Company on Tuesday, 12th August, 2025

19 Aug, 2025 | 11:00am • Source: NSE

Please find enclosed herewith the transcript of "Q1 FY2026 Earnings conference call" hosted by the Company on Tuesday, 12th August, 2025.

19 Aug, 2025 | 10:38am • Source: BSE